DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
BI-853520
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Focal adhesion kinase 1 inhibitor
BI-853520
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IMC-EB10
1
Antibody
Investigational
Unknown
Unknown
Leukemia, Myeloid
Tyrosine-protein kinase receptor FLT3 inhibitor
IMC-EB10
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VALINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
VALINE
×
Maximum Phase:
1
First Approval:
None
UNII:
HG18B9YRS7
Molecule Type:
Small molecule
Molecular Formula:
C5H11NO2
Molecular Weight:
117.15
AlogP:
0.05
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
2.0
Source:
AMV-564
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms
Unknown
AMV-564
×
Maximum Phase:
1
First Approval:
None
UNII:
56FUB33G5M
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GLIAL GROWTH FACTOR 2
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
GLIAL GROWTH FACTOR 2
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
APVO-414
1
Unknown
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Unknown
APVO-414
×
Maximum Phase:
1
First Approval:
None
UNII:
56JX9SY1PG
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BEPRANEMAB
1
Antibody
Investigational
Unknown
Unknown
Supranuclear Palsy, Progressive; Alzheimer Disease
Unknown
BEPRANEMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
9M1GV6L389
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TP-3654
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
TP-3654
×
Maximum Phase:
1
First Approval:
None
UNII:
EOB0N7BOY4
Molecule Type:
Small molecule
Molecular Formula:
C22H25F3N4O
Molecular Weight:
418.46
AlogP:
5.16
PSA:
62.45
HBD:
2.0
HBA:
#RotB:
4.0
Source:
BOTULISM ANTITOXIN
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
BOTULISM ANTITOXIN
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PHIP
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
PHIP
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OCTANOIC ACID
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Cholangiocarcinoma; Essential Tremor; Gallbladder Neoplasms; Leukemia, Myeloid, Acute; Small Cell Lung Carcinoma; Myelodysplastic Syndromes; Sarcoma, Myeloid
Unknown
OCTANOIC ACID
×
Maximum Phase:
1
First Approval:
None
UNII:
OBL58JN025
Molecule Type:
Small molecule
Molecular Formula:
C8H16O2
Molecular Weight:
144.21
AlogP:
2.43
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
6.0
Source:
BORNEOL
1
Small molecule
Investigational
Unknown
Unknown
Angina, Stable
Unknown
BORNEOL
×
Maximum Phase:
1
First Approval:
None
UNII:
M89NIB437X
Molecule Type:
Small molecule
Molecular Formula:
C10H18O
Molecular Weight:
154.25
AlogP:
2.19
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
0.0
Source:
SULTHIAME
1
Small molecule
Investigational
Unknown
Unknown
Epilepsy
Carbonic anhydrase inhibitor
SULTHIAME
×
Maximum Phase:
1
First Approval:
None
UNII:
I00Q766CZ2
Molecule Type:
Small molecule
Molecular Formula:
C10H14N2O4S2
Molecular Weight:
290.37
AlogP:
0.26
PSA:
97.54
HBD:
1.0
HBA:
#RotB:
2.0
Source:
PBF-999
1
Small molecule
Investigational
Unknown
Unknown
Huntington Disease; Neoplasms
Adenosine A2a receptor antagonist
PBF-999
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MRTX-849
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
GTPase KRas inhibitor
MRTX-849
×
Maximum Phase:
1
First Approval:
None
UNII:
8EOO6HQF8Y
Molecule Type:
Small molecule
Molecular Formula:
C32H35ClFN7O2
Molecular Weight:
604.13
AlogP:
4.73
PSA:
88.83
HBD:
0.0
HBA:
#RotB:
7.0
Source:
ATIPAMEZOLE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ATIPAMEZOLE
×
Maximum Phase:
1
First Approval:
None
UNII:
03N9U5JAF6
Molecule Type:
Small molecule
Molecular Formula:
C14H16N2
Molecular Weight:
212.3
AlogP:
2.86
PSA:
28.68
HBD:
1.0
HBA:
#RotB:
2.0
Source:
SYM-021
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
SYM-021
×
Maximum Phase:
1
First Approval:
None
UNII:
K45ZNW8WU9
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MEDI-7184
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MEDI-7184
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
WX-037
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
PI3-kinase class I inhibitor
WX-037
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VULINACIMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
VULINACIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
SA09JNQ24D
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EZABENLIMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
EZABENLIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CEP-7055
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Vascular endothelial growth factor receptor inhibitor
CEP-7055
×
Maximum Phase:
1
First Approval:
None
UNII:
AD6CBG7OXO
Molecule Type:
Small molecule
Molecular Formula:
C32H35N3O4
Molecular Weight:
525.65
AlogP:
5.03
PSA:
72.8
HBD:
1.0
HBA:
#RotB:
9.0
Source:
2'-F-ARA-DEOXYURIDINE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
2'-F-ARA-DEOXYURIDINE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AXT914
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AXT914
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TALINOLOL
1
Small molecule
Investigational
Unknown
Unknown
Cardiovascular Diseases; Obesity, Morbid
Unknown
TALINOLOL
×
Maximum Phase:
1
First Approval:
None
UNII:
3S82268BKG
Molecule Type:
Small molecule
Molecular Formula:
C20H33N3O3
Molecular Weight:
363.5
AlogP:
3.27
PSA:
82.62
HBD:
4.0
HBA:
#RotB:
7.0
Source:
ACHN-975
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ACHN-975
×
Maximum Phase:
1
First Approval:
None
UNII:
48CET2EN53
Molecule Type:
Small molecule
Molecular Formula:
C20H23N3O4
Molecular Weight:
369.42
AlogP:
0.01
PSA:
124.68
HBD:
5.0
HBA:
#RotB:
5.0
Source:
LODAPOLIMAB
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Melanoma; Neoplasms; Pancreatic Neoplasms
Unknown
LODAPOLIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
NR4MAD6PPB
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MDX-1342
1
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell
B-lymphocyte antigen CD19 binding agent
MDX-1342
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
REBAUDIOSIDE A
1
Oligosaccharide
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
REBAUDIOSIDE A
×
Maximum Phase:
1
First Approval:
None
UNII:
B3FUD0528F
Molecule Type:
Oligosaccharide
Molecular Formula:
C44H70O23
Molecular Weight:
967.02
AlogP:
-5.11
PSA:
374.13
HBD:
14.0
HBA:
#RotB:
12.0
Source:
XMAB-20717
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
XMAB-20717
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SALVIANOLIC ACID A
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus; Diabetic Neuropathies
Unknown
SALVIANOLIC ACID A
×
Maximum Phase:
1
First Approval:
None
UNII:
51622542XO
Molecule Type:
Small molecule
Molecular Formula:
C26H22O10
Molecular Weight:
494.45
AlogP:
3.34
PSA:
184.98
HBD:
7.0
HBA:
#RotB:
8.0
Source:
ELTANEXOR
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ELTANEXOR
×
Maximum Phase:
1
First Approval:
None
UNII:
Q59IQJ9NTK
Molecule Type:
Small molecule
Molecular Formula:
C17H10F6N6O
Molecular Weight:
428.3
AlogP:
3.26
PSA:
99.58
HBD:
1.0
HBA:
#RotB:
4.0
Source:
GSK-1614235
1
Unknown
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
GSK-1614235
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TPX-0131
1
Unknown
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Unknown
TPX-0131
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TUROFEXORATE ISOPROPYL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Bile acid receptor FXR agonist
TUROFEXORATE ISOPROPYL
×
Maximum Phase:
1
First Approval:
None
UNII:
S6KDM312I5
Molecule Type:
Small molecule
Molecular Formula:
C25H24F2N2O3
Molecular Weight:
438.47
AlogP:
5.17
PSA:
62.4
HBD:
1.0
HBA:
#RotB:
3.0
Source:
1
2
…
95
96
97
98
99
100
101
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA